HomeMCPWorkbenchSkills
HomeWorkbenchNotificationsMe
llms.txt · MCP GuidePrivacy Policy · Terms of Service · Supportv1.8.3
  1. Home
  2. /Compound

Mirogabalin

HCID 59509752
New reaction
Print

Completing data — refresh the page later to see the latest

Basic informationOverviewNames & identifiersPropertiesSafety & regulationChemistry & industryRelated reactionsCompound notes
Substructure searchFind similar structures

Basic information

CAS
1138245-13-2
Standard SMILES
CCC1=C[C@@H]2[C@H](C1)C[C@]2(CN)CC(=O)O
InChIKey
FTBQORVNHOIASH-CKYFFXLPSA-N
Molecular formula
C12H19NO2
Average molar mass
209.28 g/mol
Monoisotopic mass
209.14157885

Overview

Mirogabalin has been used in trials studying the treatment of Post-herpetic Neuralgia, Pain Associated With Fibromyalgia, and Diabetic peripheral neuropathic pain.

Names & identifiers

Preferred name
Mirogabalin
IUPAC
2-[(1R,5S,6S)-6-(aminomethyl)-3-ethyl-6-bicyclo[3.2.0]hept-3-enyl]acetic acid
English name
Mirogabalin
Molecular formula
C12H19NO2
Molecular weight
209.28

Names & synonyms

Mirogabalin1138245-13-22-((1R,5S,6S)-6-(aminomethyl)-3-ethylbicyclo[3.2.0]hept-3-en-6-yl)acetic acid2-[(1R,5S,6S)-6-(aminomethyl)-3-ethyl-6-bicyclo[3.2.0]hept-3-enyl]acetic acidMirogabalinaMirogabalineS7LK2KDM5UDTXSID001032301((1R,5S,6S)-6-(Aminomethyl)-3-ethylbicyclo(3.2.0)hept-3-en-6-yl)acetic acidA200-0700Bicyclo(3.2.0)hept-3-ene-6-acetic acid, 6-(aminomethyl)-3-ethyl-, (1R,5S,6S)-A-200-0700
Show more names
AsapiprantDS5565MiluobalinMirogabalin ImpurityMirogabalin Impurity 93mirobalinMilobarin
2-[(1R,5S,6S)-6-(aminomethyl)-3-ethylbicyclo[3.2.0]hept-3-en-6-yl]acetic acid[(1R,5S,6S)-6-(Aminomethyl)-3-ethylbicyclo[3.2.0]hept-3-en-6-yl]acetic acidmirogabalinum2-((1R,5S,6S)-6-(aminomethyl)-3-ethyl-6-bicyclo(3.2.0)hept-3-enyl)acetic acid2-((1R,5S,6S)-6-(aminomethyl)-3-ethylbicyclo(3.2.0)hept-3-en-6-yl)acetic acidBicyclo[3.2.0]hept-3-ene-6-acetic acid, 6-(aminomethyl)-3-ethyl-, (1R,5S,6S)-RefChem:925933DTXCID601517307

Properties

Computed structural propertiesFilling in

XLogP
-1.7
Topological polar surface area
63.3 Ų
Hydrogen bond donors
2
Hydrogen bond acceptors
3
Rotatable bonds
4
Heavy atoms
15
Formal charge
0
Complexity
311

Experimental & physicochemical properties

DrugsPharmaceuticals -> Listed in ZINC15

Physicochemical properties

Boiling point
357.5 · 357.5±15.0 °C(Predicted)
Density
1.104 · 1.104±0.06 g/cm3(Predicted)
storage temp.
-20 °C · Store at -20°C
solubility
0.5 · DMF:0.5(Max Conc. mg/mL);2.39(Max Conc. mM)Ethanol:1.25(Max Conc. mg/mL);5.97(Max Conc. mM)PBS (pH 7.2):0.5(Max Conc. mg/mL);2.39(Max Conc. mM)Water:5.36(Max Conc. mg/mL);25.61(Max Conc. mM)
form
A crystalline solid
pka
4.65 · 4.65±0.10(Predicted)
color
Light yellow to light brown
InChI
InChI=1S/C12H19NO2/c1-2-8-3-9-5-12(7-13,6-11(14)15)10(9)4-8/h4,9-10H,2-3,5-7,13H2,1H3,(H,14,15)/t9-,10-,12-/m1/s1
InChIKey
FTBQORVNHOIASH-CKYFFXLPSA-N
SMILES
[C@]12([H])[C@]([H])([C@@](CN)(CC(O)=O)C1)C=C(CC)C2

Safety & regulation

Safety information is for reference only and does not replace the supplier’s Safety Data Sheet (SDS), applicable regulations, or professional assessment.

Safety data

Signal word
Warning
Symbol(GHS)
GHS07
Hazard statements
H302-H315-H319-H335
Precautionary statements
P261-P305+P351+P338

Chemistry & industry

Pharmacology

ATC Code · 2 items

N - Nervous system

QN - Nervous system

Applications · 2 items

DescriptionMirogabalin is a calcium channel blocker with analgesic effects. It binds to the α2δ-1 and α2δ-2 subunits of voltage-dependent Ca2+ channels. Mirogabalin has potent and sustained analgesic effects (ED50 = 2.5 mg/kg) in rats with diabetes induced by streptozotocin (STZ; ). Mirogabalin does not inhibit activities associated with CNS adverse effects of analgesics, such as rotarod performance (ID50 = 9.4 mg/kg) or locomotor activity (ID50 = 43.9 mg/kg), at its effective dose. Formulations containing mirogabalin are in clinical trials for diabetic peripheral neuropathic pain.

UsesMirogabalin is a two alpha2delta ligand which is investigated for the treatment of peripheral neuropathic pain, postherpetic neuralgia and fibromyalgia, showing promising results in patients with diabetic peripheral neuropathy.

Upstream & downstream products

Upstream raw materials

tert-butyl 2-((1R,5S,6S)-6-(((tert-butoxycarbonyl)amino)methyl)-3-ethylbicyclo[3.2.0]hept-3-en-6-yl)acetateHydrochloric acidTriethylamineEthyl acetateDichloromethane

Related reactions

1 records
New reaction record
HRID 551682 reaction equation
HRID 551682As product

Compound notes

On this pageBasic informationOverviewNames & identifiersPropertiesSafety & regulationChemistry & industryRelated reactionsCompound notes

Database identifiers

CAS
1138245-13-2
PubChem CID
59509752
DTXSID
DTXSID001032301
ChEMBL
CHEMBL3545125
UNII
S7LK2KDM5U
EC Number
195-505-7
Nikkaji
J3.545.546I
FDA UNII
7 LK2KDM5U · S7LK2KDM5U
ATC code
2 BG11 · N02BG11
Symbol(GHS)
7 · GHS07
Signal word
Warning
Hazard statements
302 · H302-H315-H319-H335
Precautionary statements
261 · P261-P305+P351+P338